Xiuli Yang

机构：Guilin Medical University, Anhui Medical University, Zhejiang Provincial People's Hospital, Nanyang Medical College, First Affiliated Hospital of Anhui Medical University, Hangzhou Medical College, Shaanxi University of Chinese Medicine · ORCID：0000-0002-6912-0962

发表论文 105 篇 · 总被引 917 次 · h-index 17

代表论文

• Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial (2022 · ˜The œLancet. Gastroenterology & hepatology · 被引 88)
• Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer (2021 · Phytomedicine · 被引 45)
• Effects of Ultrasound-Guided Stellate Ganglion Block on Postoperative Quality of Recovery in Patients Undergoing Breast Cancer Surgery: A Randomized Controlled Clinical Trial (2022 · Journal of Healthcare Engineering · 被引 17)
• Anchoring subnanometric Cu 4 clusters in graphitic-C 3 N 5 for highly efficient CO 2 photoreduction to ethanol (2024 · Energy & Environmental Science · 被引 15)
• Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial (2025 · Molecular Cancer · 被引 10)
• TRIP6 promotes neural stem cell maintenance through YAP ‐mediated Sonic Hedgehog activation (2024 · The FASEB Journal · 被引 7)